Dr. Benjamin F. Jacobs Iii, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4200 Houma Blvd, Fl 2, Metairie, LA 70006 Phone: 504-454-4102 Fax: 504-454-4192 |
Dr. Patrick C. Breaux, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2005 Veterans Memorial Blvd, Metairie, LA 70002 Phone: 504-836-9820 |
Dr. Gary D. Menszer, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4200 Houma Blvd, Fl 2, Metairie, LA 70006 Phone: 504-503-4102 Fax: 504-503-4192 |
Dr. Lehman K. Preis, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4200 Houma Blvd, Fl 2, Metairie, LA 70006 Phone: 504-454-4120 Fax: 504-454-4192 |
Abhinav Saxena, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd Ste 500, Metairie, LA 70006 Phone: 504-503-4102 Fax: 504-456-6737 |
Glenn Patrick Kelley, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4200 Houma Blvd Fl 2, Metairie, LA 70006 Phone: 504-454-4102 Fax: 504-454-4192 |
Mr. Gregory D Tilton, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd Ste 500, Metairie, LA 70006 Phone: 504-455-0842 Fax: 504-503-6737 |
Dr. Fortune A. Dugan, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4200 Houma Blvd, Fl 2, Metairie, LA 70006 Phone: 504-503-4102 Fax: 504-503-4192 |
Dr. Robert W Greer, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4228 Houma Blvd Fl 3, Metairie, LA 70006 Phone: 504-410-2985 Fax: 504-503-4192 |
Dr. Homeyar K Dinshaw, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2005 Veterans Memorial Blvd, Metairie, LA 70002 Phone: 504-836-9820 |
Orlando Deffer, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd Ste 500, Metairie, LA 70006 Phone: 504-455-0842 Fax: 504-503-6737 |
Mr. William Airth Rolston Iii, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd #450a, Metairie, LA 70006 Phone: 504-454-9006 Fax: 504-456-5080 |
Monique Patrice Brimmer-williams, NP-C Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6521 Airline Dr, Metairie, LA 70003 Phone: 504-534-1226 Fax: 504-636-6695 |
Mrs. Lois Mailander, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd Ste 500, Metairie, LA 70006 Phone: 504-455-0842 Fax: 504-503-6737 |
Mr. Roland J Bourgeois Jr., MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd, Suite 500, Metairie, LA 70006 Phone: 504-455-0842 Fax: 504-455-4126 |
Nicholas Demeteius Pappas Jr., MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd Ste 500, Metairie, LA 70006 Phone: 504-455-0842 Fax: 504-503-6737 |
News Archive
After menopause, 6 to 10 million women take hormone therapies, which are often a combination of estrogen and progestin, to replace hormones lost from inactive ovaries. Progestin is a hormone that is used to counteract the potentially negative effects of estrogen therapy on the uterus. In studies sponsored by the National Institutes of Health, evidence has been found that estrogen and progestin in hormone therapies increase the risk of breast cancer in post-menopausal women.
In a unique communications partnership, the Royal Society of Medicine and ITN Productions have launched a news and current affairs-style programme.
A new weapon has emerged to prevent HIV infection. Called pre-exposure prophylaxis, or PrEP, it is a strategy of providing medications to at-risk people before they are exposed to the virus. Having shown great promise in recent phase 3 clinical trials, PrEP may soon be rolled out for public use.
New Leaf Venture Partners (NLV Partners) announced today it has led a $30 million Series D financing round in Neuronetics, Inc., maker of NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® for the treatment of depression.
› Verified 4 days ago